Thus, targeting C/EBP-δ may provide an interesting avenue for cancer therapy; through which one could simultaneously target MDSCs and tumor endothelium, two important components in the tumor microenvironment, to achieve killing two birds with one stone. The gene discussed is CEBPD; the disease is neoplasm.